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Abstract: alternatives to stop chikungunya outbreaks are oriented to vector control and developing 
a specific treatment and a preventive vaccine. Environmental control and mosquito bite prevention 
are undoubtedly essential to decrease the disease burden, but Aedes vectors continue to expand 
geographically and re-emerge. So, vaccination is proposed to respond to this etiology and recog-
nized as a pressing need for affected countries. A mathematical host-vector model, including a- 
symptomatic population, vector control, and vaccination (assuming the existence of a safe protective 
vaccine against the chikungunya virus), is suggested to analyze the effects of these efforts. Poisson 
distribution is applied to interpret the basic reproduction number. Then vaccination and vector con-
trol thresholds are established to prescribe the most effective protection measures against exposure 
to the chikungunya virus. In conclusion, it is advisable to continue with integrated control to reduce 
the economic impact of relevant public health responses and mitigate other infections since Aedes 
is a transmitter of other arboviruses such as dengue, Zika, and Mayaro. Furthermore, vaccinating all 
individuals in a community could be a costly and gradual process.
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Análisis de estrategias para prevenir y controlar el virus 
Chikunguña
Resumen: las alternativas para detener los brotes de Chikunguña están orientadas, primero, al con-
trol del vector y, segundo, al desarrollo de un tratamiento específico y una vacuna preventiva. Es 
indudable la importancia del control ambiental y la prevención de la picadura de mosquitos para 
disminuir la carga de la enfermedad, pero sus vectores Aedes continúan expandiéndose geográfica-
mente y resurgiendo, por lo que la vacunación se plantea como la respuesta a esta etiología y se re-
conoce como una necesidad prioritaria para los países afectados. Con el fin de analizar los efectos de 
los esfuerzos antes mencionados, se propone un modelo matemático hospedero-vector que incluye 
población asintomática, control de vectores y vacunación (se supone la existencia de una vacuna 
segura y protectora contra el virus Chikunguña). Se aplica el proceso de Poisson en epidemiología 
para interpretar el número básico de reproducción, y luego se establecen umbrales de vacunación y 
control vectorial que prescriben las medidas más efectivas para proteger contra la exposición al virus 
Chikunguña. Se concluye que para reducir el impacto económico de las respuestas de salud pública 
correspondientes es recomendable continuar con el control integrado, ya que Aedes es transmisor de 
otros arbovirus como dengue, Zika y Mayaro, lo que ayudaría también a la mitigación de estas otras 
infecciones. Además, proporcionar la vacuna a todos los individuos de una comunidad podría ser un 
proceso paulatino y costoso.
Palabras clave: chikv; Aedes; vacunación; control del mosquito; modelo matemático; número 
reproductivo básico
Análise de estratégias para prevenir e controlar o vírus 
Chikungunya
Resumo: as alternativas para deter os surtos de chikungunya estão orientadas, em primeiro lugar, ao 
controle do vetor e, em segundo, ao desenvolvimento de um tratamento específico e de uma vacina. 
São inegáveis a importância do controle ambiental e a prevenção da picada de mosquitos para diminuir 
a carga da doença, mas seus vetores Aedes continuam se expandindo geograficamente e ressurgindo, 
razão pela qual a vacinação se apresenta como resposta a essa etiologia e se reconhece como necessi-
dade prioritária para os países afetados. A fim de analisar os efeitos dos esforços antes mencionados, é 
proposto um modelo matemático hospedeiro-vetor que inclui população assintomática, controle de ve-
tores e vacinação (é suposta a existência de uma vacina segura e protetora contra o vírus chikungunya). 
É aplicado o processo de Poisson em epidemiologia para interpretar o número básico de reprodução e 
logo estabelecidos os parâmetros para a vacinação e o controle vetorial que as medidas mais efetivas 
prescrevem para proteger da exposição ao vírus chikungunya. Conclui-se que, para reduzir o impacto 
econômico das respostas de saúde pública correspondentes, é recomendável continuar o controle 
integrado, já que Aedes é transmissor de outros arbovírus como dengue, zika e mayaro, o que ajudaria 
também para mitigar essas outras infecções. Além disso, proporcionar a vacina a todos os indivíduos 
de uma comunidade poderia ser um processo paulatino e caro.
Palavras-chave: chikv; Aedes; vacinação; controle do mosquito; modelo matemático; número 
reprodutivo básico
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Introduction
The chikungunya virus (chikv) is an rna virus be-
longing to the alphavirus genus of the Togaviridae 
family that causes chikungunya fever. It was first 
detected in Tanzania in 1952 [1]; the first outbreaks 
of the epidemic occurred in the Makonde tribe 
(Tanzania, 1950). The name chikungunya derives 
from a word of this tribe that means “person that 
bends up” and describes the contorted posture of 
people who suffer from intense pain in their joints 
(arthralgia) [2]. 
Since 2004, chikv has expanded its global geo-
graphic distribution, causing sustained epidemics 
of unprecedented magnitude in Asia and Africa, 
although some areas of these continents are con-
sidered endemic for this disease. The virus pro-
duced outbreaks in many new territories of the 
islands in the Indian Ocean in 2006 and Italy in 
2007 when autochthonous transmission by a vi-
remic traveler returning from India was detect-
ed. At the end of 2013, the Pan American Health 
Organization (paho)/World Health Organization 
(who) received confirmation of the first autoch-
thonous cases in the Americas, with cases identi-
fied on the island of Saint Martin [3], [4].
chikv is not transmitted orally, sexually, or via 
the respiratory tract but through the bite of female 
Aedes mosquitoes, predominantly A. aegypti and A. 
albopictus, which must have previously bitten a vi-
remic (a term that describes the presence of the virus 
in the blood) person to get infected [5]. The influx of 
people infected with chikv is higher than other ar-
boviruses, and they develop clinical symptoms that 
require medical attention. 
Although not all infected people develop symp-
toms (asymptomatic), the sick person in the acute 
phase may have a high fever, severe joint pain, head-
ache, nausea, and vomiting; these symptoms remain 
for 3–10 days. The persistence of symptoms for more 
than three months, even years, characterizes the dis-
ease in its chronic phase. The most frequent symptom 
is severe joint pain. However, it is believed that, once 
exposed to the virus, individuals acquire prolonged 
immunity that protects them against reinfection [6].
The disease is only fatal in 0.4 % of those affect-
ed when patients cannot overcome the infection 
because of a weak immune system. The most 
vulnerable are the elderly, newborns, and those 
suffering from heart failure, diabetes, high blood 
pressure, cancer, autoimmune diseases, among 
others. In most infections during pregnancy, the 
virus is not transmitted to the fetus; however, there 
are occasional reports of spontaneous abortions 
after a chikv infection in the mother [7]. Although 
the infection appears to induce long-lasting pro-
tective immunity, serological studies indicate that 
between 3 and 28 % of people with antibodies to 
the virus have asymptomatic infections [8].
Regarding disease control, governments of af-
fected countries have expended considerable ef-
forts and invested millions of dollars in mosquito 
control, the mainstay of prevention and control 
[9]–[11]. Mosquito control measures that have been 
used to reduce chikv transmission may be broad-
ly categorized into three types: chemical control, 
biological control, and habitat control [12]–[14]. 
Chemical control consists of the gamut of com-
mercial synthetic chemical insecticides, includ-
ing pyrethroids and organophosphates. Biological 
control consists of measures that are derived from 
plants (e.g., essential oils), animals (e.g., predatory 
fishes), or microorganisms (e.g., Bacillus thuring-
iensis israelensis (Bti)). Habitat control consists of 
landfill cleaning and source reduction by remov-
ing water from receptacles, household contain-
ers, and even large leaves. These measures were 
researched in several studies. On Mayotte Island 
in 2009, the prevalence of chikv was found to be 
higher in individuals who did not remove breed-
ing habitat [15]; another study from India reported 
a decrease in the incidence of cases following re-
moval of breeding habitat [16], which was also as-
sociated with a decrease in larval densities in three 
studies [17]–[18].
There is no specific antiviral or commercial 
vaccine approved by the who against chikungun-
ya fever. Then, prevention and mitigation rely on 
personal protective measures and community-level 
interventions, including vector control such as the 
use of repellents (applied to the skin and in the form 
of diffusers); physical barriers such as long clothing, 
bed nets, and screens; removal of vector breeding 
habitat, and mosquito avoidance [19]–[21]. Patient 
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treatment consists of alleviating the symptoms, in-
cluding joint pain, with antipyretics, optimal anal-
gesics, and fluids [22]. 
Because A. aegypti and A. albopictus mosquitoes 
persist, enormous efforts have been made to devel-
op a commercial vaccine for chikv as a preventive 
control tool. Several technologies have been used to 
develop candidate vaccines for preclinical testing 
in animal models and phase I and II clinical trials in 
humans [23], including inactivated viral vaccines, 
live-attenuated viruses (lav), alphavirus chimeras, 
recombinant viral vaccines, consensus-based dna 
vaccines, recombinant subunit vaccines and, more 
recently, a virus-like particle (vlp) vaccine [22]. 
Four vaccine candidates have been tested in hu-
mans in a phase I clinical trial (inactivated virus, 
lav, vlp, and the measles-vectored vaccine), and 
at present, only the recombinant measles virus ex-
pressing chikv vlps has entered phase II clinical 
trials [24].
At the theoretical level, in 2016, Requena and 
Segovia formulated a mathematical model to sim-
ulate an outbreak of chikungunya in a local pop-
ulation, transmitted from a neighboring infected 
population [25]. Martínez et al. propose a predic-
tive mathematical model of chikungunya diffu-
sion in Colombia to obtain the necessary sanitary 
responses and evaluate the effectiveness of control 
actions against mosquito vectors [26].
Model formulation
We considered an epidemic model with two 
transmission routes and a single vector (Aedes ae-
gypti) for the chikv, whose assumptions are 1) there 
are no alternative hosts as sources of food; 2) the 
latent population can fall into two classes, symp-
tomatic and asymptomatic, before moving on to 
the infectious class; 3) vaccinated people acquire 
permanent immunity against infection; 4) the vi-
rus continues to replicate inside the vector until the 
mosquito dies; 5) vectors are homogeneously mixed 
in the human population; 6) vector and host can 
transmit the virus only during the infectious state; 
7) there is no transovarial transmission of the vi-
rus either in the vector or the host; 8) the birth and 
mortality rates of humans are equal.
Model variables. x1 ≡ x1(t): average number 
of susceptible people at time t; x2 ≡ x2(t): average 
number of latent people at time t; x3 ≡ x3(t): av-
erage number of symptomatic people at time t; 
x4 ≡ x4(t): average number of asymptomatic peo-
ple at time t; x3 ≡ x3(t): average number of im-
mune people at time t; y1 ≡ y1(t): average number 
of non-carrier female mosquitoes at time t; y2 ≡ 
y2(t): average number of carrier female mosqui-
toes at time t; M ≡ M(t): variable total population 
of mosquitoes; N ≡ N(t): constant total popula-
tion of humans.
Model parameters. β: probability of chikv 
transmission from infected persons to non-carrier 
mosquitoes; σ: probability of chikv transmission 
from carrier mosquitoes to susceptible people; f : 
fraction of people of the exposed class who become 
symptomatic; µ: per-head mortality rate equal to 
the per-head birth rate for humans; ϵ: mortality 
rate of the adult mosquito; γ: common transfer rate 
of humans from the exposed class to the symp-
tomatic and asymptomatic classes; θ: recovery rate 
of infected people; ω: pre-infection vaccination 
rate; π: rate of mosquito elimination through adul-
ticides, lethal traps, among others; ρ: constant in-
crement rate of non-carrier mosquitoes.
The transmission dynamics is interpreted ac-
cording to the compartmental diagram in Fig. 1 
and governed by the system of nonlinear ordinary 
differential equations (1):
Fig. 1. Flow diagram of the model (1); dashed lines rep-
resent the interactions between new infections.
Source: Own elaboration
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(1)
subject to: xm (0) ≥ 0 (m = 1, 2, 3, 4, 5) and yn (0) ≥0 
(n = 1, 2) ; µ > 0, ϵ > 0, θ > 0, ω > 0, π > 0, 0 < β < 1, 0 
< σ < 1, 0 <f <1, 0 < γ < 1.
It is possible to verify that the system (1) satis-
fies the conditions of existence and uniqueness of 
solutions in  [27]–[28]. Furthermore, the sys-
tem (1) is defined in the positively invariant set (2):
   
(2)
Indeed,
for all μ > 0, ρ > 0, and N > 0. So, x1(t) and y1 (t) are 
non-negative, particularly if t ⟶ +∞. Now, adding 
all equations of the system, we can see that
So, the value of N is constant. Similarly, consid-
ering the domain defined for the parameters and 
the initial non-negative conditions, we have
The next set establishes a domain where the 
system is mathematically and epidemiologically 
reasonable since it guarantees that the state trajec-
tories are always positive, continuous, and do not 
escape infinity.
Table 1 contains the hypothetical values that 
will be used later in the simulations with the Ma-
ple software.
Table 1. Entomological and epidemiological parameters
Parameter β σ f µ ϵ Γ
Average value 0.977 0.726 0.25 7-1 0.75
Parameter θ ω π N Ρ
Average value 0.91 0.6 0.65 299,712 2,500
Source: Own elaboration
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Basic reproduction number
The system (1) presents two stationary points. E0 
represents the chikv-free equilibrium state (3):
   
(3)
Another steady state represents the prevalence 
of chikv and contains the equilibrium state of the 
latent population in one of its components (4): 
(4)
Determining R0 is equivalent to answering 
the question: Under what conditions does the 
chikv-infected population increase, ? 
Suppose an infected individual enters an immu-
nologically virgin population. It is understood that 
there is no infection in the environment, and the 
virus is produced by the infected individual en-
tering the population in question. In this case, the 







In interpreting the controlled reproduction 
number, we notice that the term R1 gives the av-
erage number of secondary infections caused by 
a symptomatic person in an entirely susceptible 
population of humans during her/his infectious 
lifespan. Similarly, the term R2 gives the average 
number of secondary infections produced by an 
asymptomatic person in a fully susceptible popu-
lation during its infectious period. Thus, R0 gives 
the average number of secondary infections that 
an infected individual, mixed in a chikv-free pop-
ulation of humans and mosquitoes, will produce 
during her/his contagion period [29].
If we consider the transition from an infectious 
state to a state of removal as the Poisson distribu-
tion, we can interpret the basic reproduction num-
ber in detail. We have:
where
and 
The average life and infectious periods can be 
calculated utilizing this mathematical theory of ep-
idemics (Poisson distribution) in which many life 
events are the transition from a susceptible state 
to a latent state, or from a latent state to an infec-
tious state, or from an infectious state to a removal 
state. Each has a certain probability of occurrence, 
regardless of how long it has persisted in the initial 
state [30]–[31]. Hence, E[x2] = 1/(μ+γ): average du-
ration of the exposed class; E[x3] = 1/(μ+θ): average 
duration of the symptomatic class equal to the av-
erage duration of the asymptomatic class; E[y1] = 1/
(ϵ+π): life expectancy of the female mosquito.
The probabilities of permanence in each class 
are P[x1] = μ/(μ+ω): the probability of staying in 
the susceptible class; P[x2] = μ/(μ+γ): the proba-
bility of remaining in the class exposed; P[x3] = fγ/
(μ+θ): the probability of remaining in the symp-
tomatic class; [x4] = (1-f) γ/ (μ+θ): the probability 
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of remaining in the asymptomatic class; P[yi] = (ϵ)/
(ϵ+π), i = 1, 2: the probability that a female mosqui-
to will remain in the non-carrier class (i = 1) or the 
carrier class (i = 2).
Given the definition of R0 and Equations (3) 
and (4), if R0 > 1, the infected individuals at the be-
ginning of the disease will increase the number of 
new infections, and a chikv outbreak will occur. 
Instead, if R0 < 1, the sick individuals will be, as a 
population, inefficient transmitters, and the dis-
ease will eventually disappear. Mathematically, this 
means that if R0 > 1, the endemic equilibrium will 
be epidemiologically significant, and the chikv-free 
equilibrium solution will be unstable, but if R0 < 1, 
the chikv-free equilibrium solution will be the only 
globally asymptotically stable solution.
Community mitigation 
strategies
The basic reproduction number (5) deduced 
from the stability analysis naturally depends on 
the control strategies. The surfaces of the basic re-
production number as a function of both strate-
gies (vaccination and vector density reduction) are 
shown in Fig. 2. The reproduction number in the 
presence of vaccination or vector control is a de-
creasing function of ω and π; i.e., the higher the 
vaccination rate or the elimination rate of mosqui-
toes, the lower the R0. In this regard, the following 
question arises: What is the critical proportion of 
individuals that must be vaccinated or mosquitoes 
that must be eliminated so that R0 is less than 1?
Fig. 2. Basic reproduction number depending on ω and π.
Source: Own elaboration
 ◾ In the absence of vaccination and vector control, 
π = ω = 0, the basic reproduction number is
 ◾ If there is no vaccination (ω = 0), but the vector is 
controlled (π > 0), we obtain:
The graph of the threshold without vaccination 
is shown in Fig. 3. In this case, the disease is con-
trolled if R0 (0, π) < 1; that is, when π > ϵ(R0 (0, 0) 
- 1) for R0 (0, 0) > 1. Whenever R0 (0, 0) < 1, it is not 
necessary to control the vector.
R0(0, π)
 
Fig. 3. Basic reproduction number in the function of π.
Source: Own elaboration
 ◾ If people are vaccinated (ω > 0), but the vector is 
not controlled π = 0, the basic reproduction num-
ber is
The graph of the threshold without vector con-
trol is shown in Fig. 4. In this case, the disease is 
controlled if R0(ω, 0) < 1; that is, when ω > μ(R0 
(0,0) - 1) for R0(0, 0) > 1. Whenever R0(0, 0) < 1, it is 
not necessary to control the vector.
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R0(ω, 0)
Fig. 4. Basic reproduction number in the function of ω.
Source: Own elaboration
For a global understanding of the meaning of 
the basic reproduction number, we disaggregate the 
expression (6) as follows:
Note the additive and multiplicative effects of 
R0. Since the mosquito can transmit the infection 
to unvaccinated susceptible persons, the vector can 
acquire the virus from the symptomatic or asymp-
tomatic persons infected with chikv. The terms μ/
(μ + γ) and μ/(μ + ω) are the fractions of unvacci-
nated and vaccinated susceptible persons, in the 
absence of symptomatic and asymptomatic persons 
but the presence of one or a small number of carrier 
mosquitoes. The term ϵ-1 βfμ/(μ + γ) indicates the in-
cidence (new cases of chikungunya) in the suscep-
tible population not vaccinated during the lifetime 
of the mosquito, providing the number of carrier 
mosquitoes (μ+γ)-1 (μ+θ)-1 σγ.
Table 2 summarizes the control strategies based 
on the threshold (5). Although Fig. 4 indicates that 
a constant low vaccination rate (above 0.016 %) 
over time is sufficient to stop the spread of chi-
kungunya, in this case, it is possible to prioritize 
resources towards the immunization of the most 
vulnerable groups of people or with a higher risk 
of the disease. According to Fig. 3, vector control 
seems to be related to a high daily vector mortality 
rate (above 63.7 %). Furthermore, the situation R0 
(ω, 0) < R0 (0,π), illustrated in Fig. 5, holds if ϵ > μ; 
for ϵ > μ, a lower burden of chikungunya is expect-
ed when an appropriate fraction of the population 
is immunized.
Table 2. Mitigation strategies




Analysis of Strategies for Preventing and Controlling the Chikungunya Virus
Facultad de Ciencias Básicas  ■  Vol. 16(1)
continue to spread chikv. This study anticipates 
that giving a safe and protective vaccine against 
chikungunya to a community would positively re-
duce the burden of this disease. 
However, if public health authorities agree that 
an epidemic is susceptible to control, they will seek 
that programs for mitigation (and then the desir-
able eradication) be sustainable and economical. 
In the light of this study, integrated control is rec-
ommended; similar research on vector-borne dis-
eases suggests that a combination of interventions 
is likely more effective than a single intervention 
[34]–[36].
The proposed model is limited (which is a 
mathematical simplification), mainly due to the 
following reasons:
1. It is assumed that all individuals belong to a pan-
mictic population (well mixed) in which mos-
quitoes and humans have the same probabilities 
of contacting each other. This model could in-
clude a spatial variation of vector concentration.
2. The second aspect is the climatic effect on the 
vector population dynamics. Locally, tempera-
ture, precipitation, and humidity significantly 
affect the dynamics of vector-borne diseases, 
including chikungunya. This model could in-
clude the unique effects of temperature on vec-
tor parameters.
A more realistic model can be developed by 
incorporating these assumptions. The proposed 
model allows us to establish the future of the dis-
ease in a specific community, as long as the precise 
information on the specific parameters is avail-
able. It is not possible to use the results of this work 
directly on an outbreak. It must be kept in mind 
that mathematical models represent reality and 
help understand how it works under a significant 
number of assumptions.
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